Literature DB >> 11826520

[Course of insecticide resistance in Culex quinquefasciatus (Diptera: Culicidae) in a region of La Habana].

J A Bisset1, M M Rodríguez, C Díaz, A Soca.   

Abstract

The use of malathion to control mosquitoes in Cuba during 7 years until 1986 selected 2 resistance mechanisms: that of elevated activity of nonspecific esterases and that of altered acetylcholinesterase (Ache) in Culex quinquefasciatus (Say). In Havana, specifically in the area under study (Quibú River), malathion was replaced by cypermethrin in 1987 and cycles of treatment with cypermethrin have been intensively used since 1987 up to now when the populations of Aedes or Culex increase. In Culex quinquefasciatus (Say) from the Quibú River the resistance levels, mainly to malathion, declined significantly from 1986 to 1997. An increase of resistance to pyrethroid was observed during that period of 11 years. The mechanism of elevated esterases rose to a frequency of 1 and there was also an increase in the frequency of the mechanism of Ache. The esterase B1, responsible for the resistance to malathion, but not to pyrethroid, was selected in this population until 1986. Starting from the use of pyrethroid for the control in this area, 2 new phenotypes of esterases named A6 and B6, apparently related to pyrethroid resistance, were selected.

Entities:  

Mesh:

Year:  2000        PMID: 11826520

Source DB:  PubMed          Journal:  Rev Cubana Med Trop        ISSN: 0375-0760


  2 in total

1.  First studies showing high temephos resistance in Anopheles labranchiae (Diptera: Culicidae) from Tunisia.

Authors:  Ahmed Tabbabi; Jabeur Daaboub
Journal:  Afr Health Sci       Date:  2018-03       Impact factor: 0.927

2.  Evaluation of resistance to temephos insecticide in Culex pipiens pipiens larvae collected from three districts of Tunisia.

Authors:  Ahmed Tabbabi; Jabeur Daaboub; Ali Laamari; Raja Ben Cheikh; Mohamed Feriani; Chokri Boubaker; Ibtissem Ben Jha; Hassen Ben Cheikh
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.